News

Blockbusters stuck in PBS limbo

Posted 6 July 2026 AM

Two drugs projected to earn over US$30 billion in combined sales in the next few years are among seven drugs that have already stalled in the PBS listing process after securing a recommendation at this year’s March meeting, with the submissions marked ‘inactive’.

Drug applications are considered inactive when a company has not advised whether they intend to proceed or not within 60 days of receiving the ratified PBAC minutes and often flag issues with conditions of the recommendation, such as pricing.

To see the whole article, please login